Literature DB >> 20346624

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

David Moher1, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, P J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman.   

Abstract

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials. Copyright (c) 2010 Moher et al. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20346624     DOI: 10.1016/j.jclinepi.2010.03.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  548 in total

Review 1.  Effects of regular exercise on adult asthma.

Authors:  Sirpa A M Heikkinen; Reginald Quansah; Jouni J K Jaakkola; Maritta S Jaakkola
Journal:  Eur J Epidemiol       Date:  2012-04-25       Impact factor: 8.082

2.  Weight management by phone conference call: a comparison with a traditional face-to-face clinic. Rationale and design for a randomized equivalence trial.

Authors:  Kate Lambourne; Richard A Washburn; Cheryl Gibson; Debra K Sullivan; Jeannine Goetz; Robert Lee; Bryan K Smith; Matthew S Mayo; Joseph E Donnelly
Journal:  Contemp Clin Trials       Date:  2012-06-01       Impact factor: 2.226

Review 3.  A checklist for assessing the methodological quality of studies using transcranial magnetic stimulation to study the motor system: an international consensus study.

Authors:  Lucy Chipchase; Siobhan Schabrun; Leonardo Cohen; Paul Hodges; Michael Ridding; John Rothwell; Janet Taylor; Ulf Ziemann
Journal:  Clin Neurophysiol       Date:  2012-05-28       Impact factor: 3.708

4.  Translation of the Care of Persons with Dementia in their Environments (COPE) intervention in a publicly-funded home care context: Rationale and research design.

Authors:  Richard H Fortinsky; Laura N Gitlin; Laura T Pizzi; Catherine Verrier Piersol; James Grady; Julie T Robison; Sheila Molony
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

5.  Changes in weight loss and lipid profiles after a dietary purification program: a prospective case series.

Authors:  Erica Callahan
Journal:  J Chiropr Med       Date:  2013-03

6.  Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.

Authors:  Gilles Caty; Gregory Reychler; Elise Piraux; Laurette Renard; David Vancraeynest; Bertrand Tombal; Xavier Geets
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-07-27       Impact factor: 5.554

Review 7.  The role of randomized controlled trials in evidence-based urology.

Authors:  Luke T Lavallée; Dean Fergusson; Rodney H Breau
Journal:  World J Urol       Date:  2011-02-01       Impact factor: 4.226

8.  A randomized controlled clinical trial on the effectiveness of three different mouthrinses (chlorhexidine with or without alcohol and C31G), adjunct to periodontal surgery, in early wound healing.

Authors:  Anastasios M Gkatzonis; Spyridon I Vassilopoulos; Ioannis K Karoussis; Archontia Kaminari; Phoebus N Madianos; Ioannis A Vrotsos
Journal:  Clin Oral Investig       Date:  2018-02-02       Impact factor: 3.573

9.  Can preoperative imaging help to predict postoperative outcome after wisdom tooth removal? A randomized controlled trial using panoramic radiography versus cone-beam CT.

Authors:  Maria Eugenia Guerrero; Raul Botetano; Jorge Beltran; Keith Horner; Reinhilde Jacobs
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

10.  A randomized controlled pilot trial of classroom-based mindfulness meditation compared to an active control condition in sixth-grade children.

Authors:  Willoughby B Britton; Nathaniel E Lepp; Halsey F Niles; Tomas Rocha; Nathan E Fisher; Jonathan S Gold
Journal:  J Sch Psychol       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.